Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Bio-Techne (TECH) Invested Capital (2016 - 2025)

Historic Invested Capital for Bio-Techne (TECH) over the last 16 years, with Q4 2025 value amounting to $2.0 billion.

  • Bio-Techne's Invested Capital fell 324.77% to $2.0 billion in Q4 2025 from the same period last year, while for Dec 2025 it was $2.0 billion, marking a year-over-year decrease of 324.77%. This contributed to the annual value of $1.9 billion for FY2025, which is 725.24% down from last year.
  • Bio-Techne's Invested Capital amounted to $2.0 billion in Q4 2025, which was down 324.77% from $2.0 billion recorded in Q3 2025.
  • In the past 5 years, Bio-Techne's Invested Capital ranged from a high of $2.1 billion in Q3 2024 and a low of $1.8 billion during Q3 2022
  • Its 5-year average for Invested Capital is $2.0 billion, with a median of $2.0 billion in 2023.
  • Per our database at Business Quant, Bio-Techne's Invested Capital tumbled by 968.6% in 2022 and then surged by 1370.11% in 2023.
  • Over the past 5 years, Bio-Techne's Invested Capital (Quarter) stood at $2.0 billion in 2021, then fell by 7.97% to $1.8 billion in 2022, then grew by 7.47% to $2.0 billion in 2023, then grew by 5.85% to $2.1 billion in 2024, then fell by 3.25% to $2.0 billion in 2025.
  • Its Invested Capital stands at $2.0 billion for Q4 2025, versus $2.0 billion for Q3 2025 and $1.9 billion for Q2 2025.